LGT Fund Management Co Ltd. Sells 6,686 Shares of Eli Lilly and Company

Institutional investor reduces stake in pharmaceutical giant

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

LGT Fund Management Co Ltd. decreased its stake in shares of Eli Lilly and Company (NYSE:LLY) by 19.6% in the 3rd quarter, according to the company's most recent SEC filing. The firm now owns 27,431 shares of the company's stock, down from 34,117 shares previously.

Why it matters

Eli Lilly is a major pharmaceutical company with a diverse portfolio of drugs and therapies. Institutional investors like LGT Fund Management closely monitor and adjust their holdings in Lilly, providing insights into market sentiment and potential shifts in the company's performance.

The details

LGT Fund Management sold 6,686 shares of Eli Lilly and Company during the 3rd quarter, reducing its total stake to 27,431 shares. The firm's holdings in Lilly now make up approximately 1.8% of its investment portfolio, making it the 12th largest holding.

  • LGT Fund Management decreased its Eli Lilly stake in the 3rd quarter of 2026.

The players

LGT Fund Management Co Ltd.

An institutional investment firm that manages a diversified portfolio of holdings, including a significant stake in pharmaceutical company Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly researches, develops, manufactures, and commercializes a broad range of medicines and therapies for patients worldwide.

Got photos? Submit your photos here. ›

The takeaway

The reduction in LGT Fund Management's Eli Lilly holdings suggests the firm may be rebalancing its portfolio or taking a more cautious stance on the pharmaceutical sector. However, Lilly remains a significant investment for the firm, underscoring the company's continued importance in the market.